Abstract
The coordination of an activated novel anticancer drug, trans-[PtCl2(ipa)(3-pico)] (ipa = isopropylamine, 3-pico = 3-methylpyridine), to DNA in a two-step process has been studied using a combination of DFT theory and IEF–PCM approach. The computed free energy barrier for the first substitution is 16.9/16.9 kcal/mol for trans-Pt-chloroaqua → trans-/cis-Pt–guanine monoadduct, 18.7/18.7 kcal/mol for trans-Pt-chloroaqua → trans-/cis-Pt–adenine monoadduct. Barriers of 20.2/20.2 kcal/mol are evaluated for trans-Pt-diaqua → trans-/cis-Pt–guanine monoadduct, 26.0/26.0 kcal/mol for trans-Pt-diaqua → trans-/cis-Pt–adenine monoadduct. In the second substitution starting from trans-Pt–guanine monoadduct to trans-diadducts, the reaction barrier for (G–Pt–G) head-to-head formation is 22.2 kcal/mol, while 22.0 kcal/mol is evaluated for the head-to-tail configuration. Barriers for (A–Pt–G) head-to-head and head-to-tail formation are 25.7/28.9 kcal/mol, respectively. The observed preference for guanine is explained in terms of remarkable larger complexation energy for the initial reactant complex as well as the lower barrier height for the substitutions. In the competition reactions, cysteine residue stabilizes the transition state (ΔG aq/ZPE = 13.1 kcal/mol) for platination more efficiently than purine bases and other protein residues.
Graphical Abstract
References
Bancroft DP, Lepre CA, Lippard SJ (1990) J Am Chem Soc 112:6860. doi:10.1021/ja00175a020
Sherman SE, Lippard SJ (1987) Chem Rev 87:1153. doi:10.1021/cr00081a013
Eastman A (1986) Biochemistry 25:3912. doi:10.1021/bi00361a026
Fichtinger-Schepman AMJ, van Oosterom AT, Lohman PHM, Berends F (1987) Cancer Res 47:3000
Lepre CA, Strothkamp KG, Lippard SJ (1987) Biochemistry 26:5651. doi:10.1021/bi00392a011
Jamieson ER, Lippard SJ (1999) Chem Rev 99:2467. doi:10.1021/cr980421n
Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J (1985) Biochemistry 24:707. doi:10.1021/bi00324a025
Wong E, Giandomenico CM (1999) Chem Rev 99:2451. doi:10.1021/cr980420v
Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V (2003) Biochemistry 42:6321. doi:10.1021/bi0342315
Boudvillain M, Dalbies R, Aussourd C, Leng M (1995) Nucleic Acids Res 23:2381. doi:10.1093/nar/23.13.2381
Ramos-Lima FJ, Vrána O, Quiroga AG, Navarro-Ranninger C, Halámiková A, Rybníčková H, Hejmalová L, Brabec V (2006) J Med Chem 49:2640. doi:10.1021/jm0602514
Jawbry S, Freikman I, Najajreh Y, Perez JM, Gibson DJ (2005) Inorg Biochem 99:1983. doi:10.1016/j.jinorgbio.2005.06.011
Farrell N, Kelland LR, Roberts JD, Beusichem MV (1992) Cancer Res 52:5065
Bulluss GH, Knott KM, Ma ESF, Aris SM, Alvarado E, Farrell N (2006) Inorg Chem 45:5733. doi:10.1021/ic060741m
McGowan G, Parsons S, Sadler PJ (2005) Inorg Chem 44:7459. doi:10.1021/ic050763t
Martínez A, Lorenzo J, Prieto MJ, Font-Bardia M, Solans X, Avilés FX, Moreno V (2007) Bioorg Med Chem 15:969. doi:10.1016/j.bmc.2006.10.031
Anzellotti A, Stefan S, Gibson D, Farrell N (2006) Inorg Chim Acta 359:3014. doi:10.1016/j.ica.2005.12.060
Horvath G, Premkumar T, Boztas A, Lee E, Jon S, Geckeler KE (2008) Mol Pharm 5:358. doi:10.1021/mp700144t
Montero EI, Diaz S, Gonzalez-Vadillo AM, Perez JM, Alonso C, Navarro-Ranninger C (1999) J Med Chem 42:4264. doi:10.1021/jm991015e
Murray M, Cunningam J, Parada L, Dantry F, Labowitz P, Weinberg R (1983) Cell 33:749. doi:10.1016/0092-8674(83)90017-X
Pèrez JM, Montero EI, Solans X, Font-Bardia M, Fuertes MA, Alonso C, Navarro-Ranninger C (2000) J Med Chem 43:2411. doi:10.1021/jm000925p
Beusichem MV, Farrell N (1992) Inorg Chem 31:634. doi:10.1021/ic00030a021
Quiroga AG, Pérez JM, Alonso C, Navarro-Ranninger C, Farrell N (2006) J Med Chem 49:224. doi:10.1021/jm050804v
Zou Y, Houten BV, Farrell N (1993) Biochemistry 32:9632. doi:10.1021/bi00088a015
Gao Y, Zhou LX (2008) Chin J Chem Phys 21:346
Davies MS, Berners-Price SJ, Hambley TW (2000) Inorg Chem 39:5603. doi:10.1021/ic000847w
Legendre F, Bas V, Kozelka J, Chottard JC (2000) Chem Eur J 6:2002. doi:10.1002/1521-3765(20000602)6:11<2002::AID-CHEM2002>3.0.CO;2-H
Zimmermann T, Zeizinger M, Burda JV (2005) J Inorg Biochem 99:2184. doi:10.1016/j.jinorgbio.2005.07.021
Fojo T, Farrell N, Ortuzar W, Tanimura H, Weinstein J, Myers TG (2005) Crit Rev Oncol Hematol 53:25. doi:10.1016/j.critrevonc.2004.09.008
Farrell N, Povirk LF, Dange Y, DeMasters G, Gupta MS, Kohlhagen G, Khan QA, Pommier Y, Gewirtz DA (2004) Biochem Pharmacol 68:857. doi:10.1016/j.bcp.2004.05.023
Hohenberg P, Kohn W (1964) Phys Rev B136:864. doi:10.1103/PhysRev.136.B864
Becke AD (1993) J Chem Phys 98:5648. doi:10.1063/1.464913
Lee C, Yang W, Parr RG (1988) Phys Rev B37:785. doi:10.1103/PhysRevB.37.785
Hay PJ, Wadt WR (1985) J Chem Phys 82:270. doi:10.1063/1.448799
Wadt WR, Hay PJ (1985) J Chem Phys 82:284. doi:10.1063/1.448800
Hay PJ, Wadt WR (1985) J Chem Phys 82:299. doi:10.1063/1.448975
Binkley JS, Pople JA, Hehre WJ (1980) J Am Chem Soc 102:939. doi:10.1021/ja00523a008
Hehre WJ, Ditchfield R, Pople JA (1972) J Chem Phys 56:2257. doi:10.1063/1.1677527
Gonzalez C, Schlegel HB (1989) J Chem Phys 90:2154. doi:10.1063/1.456010
Gonzalez C, Schlegel HB (1990) J Phys Chem 94:5523. doi:10.1021/j100377a021
McLean AD, Chandler GS (1980) J Chem Phys 72:5639. doi:10.1063/1.438980
Kirkwood JG (1934) J Chem Phys 2:351. doi:10.1063/1.1749489
Wong MW, Frish MJ, Wiberg KB (1991) J Am Chem Soc 113:4776. doi:10.1021/ja00013a010
Wong MW, Wiberg KB, Frish MJ (1992) J Am Chem Soc 114:523. doi:10.1021/ja00028a019
Wong MW, Wiberg KB, Frish MJ (1992) J Am Chem Soc 114:1645. doi:10.1021/ja00031a017
Onsager L (1936) J Am Chem Soc 58:1486. doi:10.1021/ja01299a050
Mennucci B, Tomasi J (1997) J Chem Phys 106:5151. doi:10.1063/1.473558
Mennucci B, Cancs E, Tomasi J (1997) J Phys Chem B 101:10506. doi:10.1021/jp971959k
Tomasi J, Mennucci B, Cancs E (1999) J Mol Struct Theochem 464:211. doi:10.1016/S0166-1280(98)00553-3
Boys SF, Bernardi F (1970) Mol Phys 19:553. doi:10.1080/00268977000101561
Simon J, Duran M, Dannenberg JJ (1996) J Chem Phys 105:11024. doi:10.1063/1.472902
Gaussian 03, revision D.01, Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2004) Gaussian, Inc., Wallingford CT
Reedijk J (2003) Proc Natl Acad Sci USA 100:3611. doi:10.1073/pnas.0737293100
Chval Z, Šip M (2003) Collect Czech Chem Commun 68:1105. doi:10.1135/cccc20031105
Reedijk J (1992) Inorg Chim Acta 200:873. doi:10.1016/S0020-1693(00)92433-2
Baik MH, Friesner RA, Lippard SJ (2003) J Am Chem Soc 125:14082. doi:10.1021/ja036960d
Raber JR, Zhu CB, Eriksson LA (2005) J Phys Chem B 109:11006. doi:10.1021/jp050057d
Clarke MJ, Sadler PJ (1999) In: Natile G, Coluccia M (eds) Topics in biological inorganic chemistry, metallopharmaceuticals. Springer, Berlin, p 73
Teuben JM, Reedijk J (2000) J Biol Inorg Chem 5:463
Hahn M, Kleine M, Sheldrick WS (2001) J Biol Inorg Chem 6:556. doi:10.1007/s007750100232
Fakih S, Munk VP, Shipman MA, Murdoch PD, Parkinson JA, Sadler PJ (2003) Eur J Inorg Chem 1206. doi:10.1002/ejic.200390156
Murdoch PD, Kratchowil NA, Parkinson JA, Patriarca M, Sadler PJ (1999) Angew Chem Int Ed 38:2949. doi:10.1002/(SICI)1521-3773(19991004)38:19<2949::AID-ANIE2949>3.0.CO;2-Q
Marchán V, Moreno V, Pedroso E, Grandas A (2001) Chem Eur J 7:808. doi:10.1002/1521-3765(20010216)7:4<808::AID-CHEM808>3.0.CO;2-6
Bierbach U, Farrell N (1998) J Biol Inorg Chem 3:570. doi:10.1007/s007750050270
Kasparkova J, Novakova O, Farrell N, Brabec V (2003) Biochemistry 42:792. doi:10.1021/bi026614t
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gao, Y., Zhou, L. DNA bindings of a novel anticancer drug, trans-[PtCl2(isopropylamine)(3-picoline)], and kinetic competition of purine bases with protein residues in the bifunctional substitutions: a theoretical DFT study. Theor Chem Acc 123, 455–468 (2009). https://doi.org/10.1007/s00214-009-0557-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00214-009-0557-5